A citation-based method for searching scientific literature

A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani, Mauro A A Castro, Ewan A Gibb, Rupa S Kanchi, Dmitry A Gordenin, Sachet A Shukla, Francisco Sanchez-Vega, Donna E Hansel, Bogdan A Czerniak, Victor E Reuter, Xiaoping Su, Benilton de Sa Carvalho, Vinicius S Chagas, Karen L Mungall, Sara Sadeghi, Chandra Sekhar Pedamallu, Yiling Lu, Leszek J Klimczak, Jiexin Zhang, Caleb Choo, Akinyemi I Ojesina, Susan Bullman, Kristen M Leraas, Tara M Lichtenberg, Catherine J Wu, Nicholaus Schultz, Gad Getz, Matthew Meyerson, Gordon B Mills, David J McConkey, John N Weinstein, David J Kwiatkowski, Seth P Lerner. Cell 2017
Times Cited: 768







List of co-cited articles
558 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Woonyoung Choi, Sima Porten, Seungchan Kim, Daniel Willis, Elizabeth R Plimack, Jean Hoffman-Censits, Beat Roth, Tiewei Cheng, Mai Tran, I-Ling Lee,[...]. Cancer Cell 2014
849
34

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, Gottfrid Sjödahl, A Gordon Robertson, Roland Seiler, Katherine A Hoadley, Clarice S Groeneveld, Hikmat Al-Ahmadie, Woonyoung Choi,[...]. Eur Urol 2020
174
29

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Jonathan E Rosenberg, Jean Hoffman-Censits, Tom Powles, Michiel S van der Heijden, Arjun V Balar, Andrea Necchi, Nancy Dawson, Peter H O'Donnell, Ani Balmanoukian, Yohann Loriot,[...]. Lancet 2016
23

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Roland Seiler, Hussam Al Deen Ashab, Nicholas Erho, Bas W G van Rhijn, Brian Winters, James Douglas, Kim E Van Kessel, Elisabeth E Fransen van de Putte, Matthew Sommerlad, Natalie Q Wang,[...]. Eur Urol 2017
348
22

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Joaquim Bellmunt, Ronald de Wit, David J Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J Vogelzang, Miguel A Climent, Daniel P Petrylak, Toni K Choueiri,[...]. N Engl J Med 2017
17

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, Thomas Powles, Daniel P Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman-Censits, Jose Luis Perez-Gracia,[...]. Lancet 2017
939
16

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.
Jeffrey S Damrauer, Katherine A Hoadley, David D Chism, Cheng Fan, Christopher J Tiganelli, Sara E Wobker, Jen Jen Yeh, Matthew I Milowsky, Gopa Iyer, Joel S Parker,[...]. Proc Natl Acad Sci U S A 2014
460
15

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, Yulei Wang, Edward E Kadel, Hartmut Koeppen, Jillian L Astarita, Rafael Cubas,[...]. Nature 2018
14

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
Yohann Loriot, Andrea Necchi, Se Hoon Park, Jesus Garcia-Donas, Robert Huddart, Earle Burgess, Mark Fleming, Arash Rezazadeh, Begoña Mellado, Sergey Varlamov,[...]. N Engl J Med 2019
296
14

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, Ferran Algaba, Søren Høyer, Benedicte Parm Ulhøi, Søren Vang, Thomas Reinert, Gregers G Hermann, Karin Mogensen,[...]. Cancer Cell 2016
266
13

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Thomas Powles, Ignacio Durán, Michiel S van der Heijden, Yohann Loriot, Nicholas J Vogelzang, Ugo De Giorgi, Stéphane Oudard, Margitta M Retz, Daniel Castellano, Aristotelis Bamias,[...]. Lancet 2018
584
13

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.
Andrea Necchi, Andrea Anichini, Daniele Raggi, Alberto Briganti, Simona Massa, Roberta Lucianò, Maurizio Colecchia, Patrizia Giannatempo, Roberta Mortarini, Marco Bianchi,[...]. J Clin Oncol 2018
209
13

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb, Michiel S Van Der Heijden, Bernadett Szabados, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz,[...]. Nat Med 2019
133
12


A molecular taxonomy for urothelial carcinoma.
Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren, Gunilla Chebil, Sigurdur Gudjonsson, Srinivas Veerla, Oliver Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér,[...]. Clin Cancer Res 2012
425
11

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.
Elizabeth R Plimack, Roland L Dunbrack, Timothy A Brennan, Mark D Andrake, Yan Zhou, Ilya G Serebriiskii, Michael Slifker, Katherine Alpaugh, Essel Dulaimi, Norma Palma,[...]. Eur Urol 2015
244
11

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Padmanee Sharma, Margitta Retz, Arlene Siefker-Radtke, Ari Baron, Andrea Necchi, Jens Bedke, Elizabeth R Plimack, Daniel Vaena, Marc-Oliver Grimm, Sergio Bracarda,[...]. Lancet Oncol 2017
768
11

Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
David Liu, Elizabeth R Plimack, Jean Hoffman-Censits, Levi A Garraway, Joaquim Bellmunt, Eliezer Van Allen, Jonathan E Rosenberg. JAMA Oncol 2016
116
10

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.
Eliezer M Van Allen, Kent W Mouw, Philip Kim, Gopa Iyer, Nikhil Wagle, Hikmat Al-Ahmadie, Cong Zhu, Irina Ostrovnaya, Gregory V Kryukov, Kevin W O'Connor,[...]. Cancer Discov 2014
309
10

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
Eugene J Pietzak, Aditya Bagrodia, Eugene K Cha, Esther N Drill, Gopa Iyer, Sumit Isharwal, Irina Ostrovnaya, Priscilla Baez, Qiang Li, Michael F Berger,[...]. Eur Urol 2017
136
9

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
Andrea Necchi, Daniele Raggi, Andrea Gallina, Jeffrey S Ross, Elena Farè, Patrizia Giannatempo, Laura Marandino, Maurizio Colecchia, Roberta Lucianò, Marco Bianchi,[...]. Eur Urol 2020
40
22


First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.
Arjun V Balar, Daniel Castellano, Peter H O'Donnell, Petros Grivas, Jacqueline Vuky, Thomas Powles, Elizabeth R Plimack, Noah M Hahn, Ronald de Wit, Lei Pang,[...]. Lancet Oncol 2017
531
9

Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.
Randy F Sweis, Stefani Spranger, Riyue Bao, Gladell P Paner, Walter M Stadler, Gary Steinberg, Thomas F Gajewski. Cancer Immunol Res 2016
173
9

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.
Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley M Regazzi, Brooke E Kania, Meredith M Moran, Catharine K Cipolla, Mark J Bluth, Joshua Chaim, Hikmat Al-Ahmadie,[...]. J Clin Oncol 2018
206
9

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma.
Min Yuen Teo, Richard M Bambury, Emily C Zabor, Emmet Jordan, Hikmat Al-Ahmadie, Mariel E Boyd, Nancy Bouvier, Stephanie A Mullane, Eugene K Cha, Nitin Roper,[...]. Clin Cancer Res 2017
119
9

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
9

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
J Alfred Witjes, Harman Max Bruins, Richard Cathomas, Eva M Compérat, Nigel C Cowan, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós, Anja Lorch, Yann Neuzillet,[...]. Eur Urol 2021
129
9

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
Sebastien Antoni, Jacques Ferlay, Isabelle Soerjomataram, Ariana Znaor, Ahmedin Jemal, Freddie Bray. Eur Urol 2017
8

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.
Emil Christensen, Karin Birkenkamp-Demtröder, Himanshu Sethi, Svetlana Shchegrova, Raheleh Salari, Iver Nordentoft, Hsin-Ta Wu, Michael Knudsen, Philippe Lamy, Sia Viborg Lindskrog,[...]. J Clin Oncol 2019
91
8

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
Simeon U Springer, Chung-Hsin Chen, Maria Del Carmen Rodriguez Pena, Lu Li, Christopher Douville, Yuxuan Wang, Joshua David Cohen, Diana Taheri, Natalie Silliman, Joy Schaefer,[...]. Elife 2018
66
12

The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability.
Jaegil Kim, David Kwiatkowski, David J McConkey, Joshua J Meeks, Samuel S Freeman, Joaquim Bellmunt, Gad Getz, Seth P Lerner. Eur Urol 2019
57
14

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Matthew D Galsky, José Ángel Arranz Arija, Aristotelis Bamias, Ian D Davis, Maria De Santis, Eiji Kikuchi, Xavier Garcia-Del-Muro, Ugo De Giorgi, Marina Mencinger, Kouji Izumi,[...]. Lancet 2020
126
8

Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts,[...]. Nature 2013
7

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
Carolyn D Hurst, Olivia Alder, Fiona M Platt, Alastair Droop, Lucy F Stead, Julie E Burns, George J Burghel, Sunjay Jain, Leszek J Klimczak, Helen Lindsay,[...]. Cancer Cell 2017
107
7

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.
Floris H Groenendijk, Jeroen de Jong, Elisabeth E Fransen van de Putte, Magali Michaut, Andreas Schlicker, Dennis Peters, Arno Velds, Marja Nieuwland, Michel M van den Heuvel, Ron M Kerkhoven,[...]. Eur Urol 2016
113
7

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.
Manish R Patel, John Ellerton, Jeffrey R Infante, Manish Agrawal, Michael Gordon, Raid Aljumaily, Carolyn D Britten, Luc Dirix, Keun-Wook Lee, Mathew Taylor,[...]. Lancet Oncol 2018
277
7

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
H von der Maase, S W Hansen, J T Roberts, L Dogliotti, T Oliver, M J Moore, I Bodrogi, P Albers, A Knuth, C M Lippert,[...]. J Clin Oncol 2000
7

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling.
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, Weisi Liu, Kailyn Li, Tyler J Moss, Rohan Bareja, Kyung Park, Peyman Tavassoli, Joanna Cyrta,[...]. Nat Commun 2019
51
13

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
Thomas Powles, Se Hoon Park, Eric Voog, Claudia Caserta, Begoña P Valderrama, Howard Gurney, Haralabos Kalofonos, Siniša Radulović, Wim Demey, Anders Ullén,[...]. N Engl J Med 2020
108
7

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
Emil Christensen, Karin Birkenkamp-Demtröder, Iver Nordentoft, Søren Høyer, Kirstin van der Keur, Kim van Kessel, Ellen Zwarthoff, Mads Agerbæk, Torben Falck Ørntoft, Jørgen Bjerggaard Jensen,[...]. Eur Urol 2017
90
6

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.
Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, May-Linda Lepage, Clémentine Krucker, Elodie Chapeaublanc, Aurélie Hérault, Aurélie Kamoun, Aurélie Caillault, Eric Letouzé,[...]. Sci Transl Med 2014
170
6

Bladder cancer.
Ashish M Kamat, Noah M Hahn, Jason A Efstathiou, Seth P Lerner, Per-Uno Malmström, Woonyoung Choi, Charles C Guo, Yair Lotan, Wassim Kassouf. Lancet 2016
497
6

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
Gottfrid Sjödahl, Pontus Eriksson, Fredrik Liedberg, Mattias Höglund. J Pathol 2017
140
6

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
Neeraj Agarwal, Sumanta K Pal, Andrew W Hahn, Roberto H Nussenzveig, Gregory R Pond, Sumati V Gupta, Jue Wang, Mehmet A Bilen, Gurudatta Naik, Pooja Ghatalia,[...]. Cancer 2018
47
12

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
6

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
6

Genomic Characterization of Upper Tract Urothelial Carcinoma.
John P Sfakianos, Eugene K Cha, Gopa Iyer, Sasinya N Scott, Emily C Zabor, Ronak H Shah, Qinghu Ren, Aditya Bagrodia, Philip H Kim, A Ari Hakimi,[...]. Eur Urol 2015
116
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.